Literature DB >> 1277434

Echocardiographic evaluation of the stent mounted aortic bioprosthetic valve in the mitral position. In vitro and in vivo studies.

M S Horowitz, P L Tecklenberg, D J Goodman, D C Harrison, R L Popp.   

Abstract

Echocardiograms were performed on 20 clinically stable patients following mitral valve replacement with glutaraldehyde-preserved porcine aortic heterografts and three patients with antibiotic sterilized aortic homografts mounted in the mitral position. Such valves were evaluated in a test chamber at varied flow rates resulting in improved understanding of movements seen with the echocardiogram in vivo. The technique for recording the valvular stent and leaflets is described and a method for measuring several parameters is demonstrated. Initial diastolic slope averaged 2.4 +/- 0.5 cm/sec (range 1.9 to 3.3 cm/sec). Left ventricular outflow tract measured from the anterior portion of the stent to the interventricular septum averaged 1.5 +/- 0.5 cm at end-diastole and 1.3 +/- 0.6 cm at end-systole. Leaflet excursion averaged 1.5 +/- 0.3 cm (with a range from 1.0 to 2.1 cm). The ratio of internal to external stent diameters averaged 0.66 +/- 0.05 (with a range from 0.56 to 0.74).

Entities:  

Mesh:

Year:  1976        PMID: 1277434     DOI: 10.1161/01.cir.54.1.91

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  3 in total

1.  Noninvasive assessment of the Ionescu-Shiley pericardial xenograft in the mitral position: preliminary experience.

Authors:  L W Pechacek; L G Solana; C M DeCastro; S K Edelman; E Garcia; R J Hall
Journal:  Tex Heart Inst J       Date:  1982-09

2.  Valvar prosthetic dysfunction. Localisation and evaluation of the dysfunction using the Doppler technique.

Authors:  C Veyrat; S Witchitz; A Lessana; A Ameur; G Abitbol; D Kalmanson
Journal:  Br Heart J       Date:  1985-09

3.  Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.

Authors:  J M Hoeg; S J Demosky; E J Schaefer; T E Starzl; H B Brewer
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.